Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E22.66 EPS (ttm)5.42 Insider Own0.06% Shs Outstand2.68B Perf Week0.19%
Market Cap329.48B Forward P/E14.32 EPS next Y8.58 Insider Trans-9.22% Shs Float2.68B Perf Month-0.49%
Income14.85B PEG2.91 EPS next Q2.06 Inst Own68.10% Short Float0.67% Perf Quarter-1.81%
Sales78.69B P/S4.19 EPS this Y-8.50% Inst Trans-0.38% Short Ratio2.71 Perf Half Y-12.98%
Book/sh23.58 P/B5.21 EPS next Y5.63% ROA0.80% Target Price145.10 Perf Year-9.71%
Cash/sh5.67 P/C21.67 EPS next 5Y7.79% ROE1.80% 52W Range118.62 - 148.32 Perf YTD-12.08%
Dividend3.36 P/FCF35.25 EPS past 5Y7.10% ROI15.70% 52W High-17.18% Beta0.74
Dividend %2.74% Quick Ratio1.20 Sales past 5Y2.60% Gross Margin66.30% 52W Low3.56% ATR1.62
Employees134000 Current Ratio1.60 Sales Q/Q12.60% Oper. Margin22.30% RSI (14)49.80 Volatility1.33% 1.30%
OptionableYes Debt/Eq0.51 EPS Q/Q-0.40% Profit Margin1.60% Rel Volume0.70 Prev Close121.45
ShortableYes LT Debt/Eq0.47 EarningsJul 17 BMO Payout616.60% Avg Volume6.66M Price122.84
Recom2.40 SMA200.74% SMA50-1.26% SMA200-7.82% Volume4,632,043 Change1.14%
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
May-15-17Upgrade JP Morgan Neutral → Overweight
Jan-26-17Downgrade Wells Fargo Outperform → Market Perform
Jun-22-18 04:15PM  J&J's Drug Unit Chief Expands Portfolio in Executive Shakeup Bloomberg
03:29PM  [$$] Johnson & Johnson Remakes Top Leadership The Wall Street Journal
12:31PM  Johnson & Johnson Appoints Senior Leaders to Executive Committee PR Newswire
12:30PM  Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson PR Newswire
Jun-21-18 04:04PM  Crowning Achievement: Six Dividend Kings With 50+ Years of Rising Dividends TheStreet.com
12:27PM  This one factor has determined which stocks rise or fall on trade-war fears MarketWatch
Jun-20-18 06:01AM  Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks Motley Fool
06:00AM  Heres how much Houston public companies spent on litigation in 2017 American City Business Journals
Jun-19-18 03:09PM  The Charts and Indicators on Johnson & Johnson Are Still Mostly Bearish TheStreet.com
02:07PM  Opioid Ruling Could Send  Purdue, Drugmakers to Court Bloomberg
10:04AM  Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results PR Newswire
07:10AM  3 Stocks That Are Absurdly Cheap Right Now Motley Fool
04:45AM  FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019 Reuters
Jun-18-18 06:42PM  Cramer floats idea for 'gloomy' ETF with Wall Street's mo... CNBC Videos
06:30PM  Cramer floats idea for 'gloomy' ETF CNBC Videos
04:18PM  Markets Right Now: Stocks look to recover from early skid Associated Press
04:04PM  3 Great Stocks for Retirees to Own TheStreet.com
10:13AM  After split from Actelion, Idorsia CEO plans to raise more cash in 2019 Reuters
09:19AM  FOCUS-After split from Actelion, Idorsia CEO plans to raise more cash in 2019 Reuters
08:42AM  Why Geron Corporation Stock Is Heading Higher Today Motley Fool
08:27AM  FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio PR Newswire
07:27AM  UNF, Mayo experiment with rare 3-D microscope American City Business Journals
Jun-17-18 12:03PM  Big Pharma Stock Investors Beware: Another $250 Billion Patent Cliff Is Coming Motley Fool
10:06AM  Better Buy: Johnson & Johnson vs. Eli Lilly Motley Fool
06:31AM  Better Buy: Pfizer Inc. vs. Johnson & Johnson Motley Fool
Jun-16-18 11:54PM  [$$] Global pharma bleeds talent to China start-ups Financial Times
Jun-15-18 05:01PM  LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1 Moody's
01:49PM  [$$] Can Investment Performance Be Predicted? Barrons.com
11:52AM  7 Perfect Dividend Stocks InvestorPlace
10:55AM  Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III Zacks
10:50AM  10 Best Stocks to Buy and Hold Forever InvestorPlace
09:25AM  Dow 30 Stock Roundup: Caterpillar Raises Dividend, Merck's Keytruda Gets FDA Nod Zacks
09:04AM  Zacks Industry Outlook Highlights: Becton and Dickinson, Johnson & Johnson, Cigna and CVS Health Zacks
07:25AM  Estimating The Fair Value Of Johnson & Johnson (NYSE:JNJ) Simply Wall St.
Jun-14-18 08:30PM  Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed. PR Newswire
05:38PM  Growth & Income Buys | Johnson & Johnson and International Paper Zacks
01:41PM  5 AI Biotech Stocks to Bet On Now InvestorPlace
08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within Southwestern Energy, Johnson & Johnson, Sleep Number, QUALCOMM, Kirkland's, and Grupo Aval Acciones y Valores S.A New Research Emphasizes Economic Growth GlobeNewswire
Jun-13-18 04:34PM  Time Warner, Twenty-First Century Fox rise; H&R Block sinks Associated Press
04:27PM  Deals of the day-Mergers and acquisitions Reuters
10:41AM  J&J (JNJ) Accepts Platinum Equity's Offer for LifeScan Unit Zacks
Jun-12-18 08:12PM  [$$] Ever Heard of Iqvia? Its CEO Made $38 Million The Wall Street Journal
05:25PM  AI And Robotics Are Taking Robotic Surgery To New Levels Investor's Business Daily
05:13PM  [$$] Iqvia? Its CEO Was the Highest Paid Pharma Chief The Wall Street Journal
05:02PM  [$$] Johnson & Johnson Accepts Platinum Equity's $2.1 Billion Offer for LifeScan Business The Wall Street Journal
04:31PM  J&J Formally Accepts $2.1 Billion Offer for Diabetes Device Unit Bloomberg
04:30PM  J&J accepts $2.1 billion bid for its LifeScan diabetes business CNBC
04:26PM  J&J accepts $2.1 billion offer for its LifeScan unit Reuters
04:18PM  Why Dow's J&J May Try To Sweep Boston Scientific From Stryker Investor's Business Daily
04:12PM  Johnson & Johnson accepts $2.1B deal for LifeScan business MarketWatch
04:12PM  J&J accepts $2.1 bln offer for its LifeScan unit Reuters
04:01PM  Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. PR Newswire
10:24AM  Lilly & AstraZeneca Scrap Studies on Alzheimer's Candidate Zacks
10:04AM  Amgen Gets FDA Nod to Add ASPIRE Data on Kyprolis Label Zacks
09:25AM  Alzheimer's Research Stumbles Again: What's the Road Ahead? Zacks
08:30AM  Stryker Likely to Acquire Boston Scientific, Shares Down Zacks
07:58AM  Pharma R&D Investments Moderating -- But Still High Forbes
12:40AM  [$$] AstraZeneca and Eli Lilly scrap Alzheimers drug trial Financial Times
Jun-11-18 04:16PM  Better Buy: Verizon Communications Inc. vs. Johnson & Johnson Motley Fool
02:21PM  Investors ready to resuscitate Johnson & Johnson's ailing stock Reuters
Jun-09-18 10:15AM  3 Top Dividend Stocks to Buy in June Motley Fool
Jun-08-18 04:22PM  Bourdain, Spade suicides highlight need for new depression drugs Reuters
02:41PM  J&J Exec Makes First Microsoft Insider Stock Buy Since 2015 Barrons.com
10:53AM  Dying Patients Seeking Drugs Face Reality Check on Right to Try Bloomberg
09:21AM  3 Dividend Stocks Perfect for Retirees Motley Fool
08:18AM  Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson Motley Fool
Jun-07-18 10:43PM  Asian shares fall ahead of G7 summit, central bank meetings Associated Press
06:50PM  Cramer: Don't be afraid to pay up for best-of-breed stock... CNBC Videos
04:37PM  Fortive offers $2.7 billion to buy Johnson & Johnson's medical-equipment sterilization business American City Business Journals
01:19PM  Allergan on an upswing, Vail Resorts soars, Johnson & Johnson dips Yahoo Finance
11:08AM  Allergan, Vail Resorts and Johnson & Johnson are the Yahoo Finance charts of the day. Yahoo Finance Video
10:39AM  China will see the biggest boost in World Cup ad dollars even though it didnt qualify CNBC
10:11AM  J&J Receives Buyout Offer for Sterilization Products Unit Zacks
09:24AM  Stocks to Watch: Boeing, Tesla, Allergan, Amazon, Alibaba, Smucker The Wall Street Journal
08:14AM  Stocks making the biggest moves premarket: SJM, THO, FIVE, UNFI, ZS, AGN, JNJ, TRUE & more CNBC
07:58AM  Benzinga's Daily Biotech Pulse: Johnson & Johnson to Dispose Sterilization Products Business, Mixed Results From Protesostasis' Cystic Fibrosis Study Benzinga
Jun-06-18 08:49PM  [$$] Fortive Offers $2.7 Billion for J&J's Medical-Equipment Sterilization Business The Wall Street Journal
06:34PM  J&J gets $2.7 billion offer for sterilization unit from Fortive Reuters
06:31PM  J&J gets $2.7 bln offer for sterilization unit from Fortive Reuters
05:21PM  In Missouri, J&J faces biggest trial yet alleging talc caused cancer Reuters
05:12PM  J&J to sell sterilization unit to Fortive for $2.7 billion Reuters
05:04PM  Fortive to acquire Johnson & Johnson sterilization business for $2.7 billion MarketWatch
04:48PM  Fortive offers $2.7 bln for J&J unit's sterilization business Reuters
04:46PM  Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP) PR Newswire
03:21PM  Corrections & Amplifications The Wall Street Journal
11:53AM  Boston U. boosts lung cancer research with Johnson & Johnson Associated Press
11:17AM  The Top 4 UPS Shareholders (UPS) Investopedia
05:00AM  J&J Faces High-Stakes Trial Over 22 Women's Talc Claims Bloomberg
Jun-05-18 09:31PM  Is an Acquisition in Portola Pharmaceuticals' Future? Motley Fool
05:26PM  Sanofi, Merck and J&J Tout Lower Drug Prices TheStreet.com
08:00AM  Johnson & Johnson Announces Progress Toward Health for Humanity Goals PR Newswire
Jun-04-18 09:00AM  James Allison, Ph.D., Wins 2018 Dr. Paul Janssen Award for Biomedical Research PR Newswire
Jun-03-18 06:35PM  U.S. FDA wants to shorten new drug monopolies to cut costs Reuters
Jun-01-18 12:26PM  Imerys unit settles talc claims for at least $5 million: Bloomberg Reuters
10:25AM  Imerys Unit Said to Settle Talc Claims for at Least $5 Million Bloomberg
07:30AM  Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks ACCESSWIRE
May-31-18 11:30PM  [$$] Big Pharma on mission to bring immunotherapy to more patients Financial Times
10:58AM  Top Diabetes Stocks to Buy Today Motley Fool
May-30-18 03:39PM  7 Inflation-Beating Stocks to Consider for This New Reality InvestorPlace
08:10AM  Add Bucks County to list of those suing opioid manufacturers, distributors American City Business Journals
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Option Exercise72.54102,6927,449,278230,342Jul 26 11:49 AM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Sale133.14102,69213,672,629127,650Jul 26 11:49 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Option Exercise61.7582,5915,099,994226,693Jul 24 11:06 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Sale136.7282,59111,291,478144,102Jul 24 11:06 AM